Managing sedation and controlling delirium are among the essential pillars of caring for ventilated patients in intensive care, to ensure their safety and facilitate weaning from mechanical ventilation. This requires a careful balance between providing comfort to the patient and avoiding drug excess and its serious toxic and cognitive complications.
Sedation assessment and its clinical goals
The RASS scale is used to determine levels of sedation and consciousness, ranging from +4 for the extremely aggressive and agitated patient (combative) to -5 for the completely unresponsive patient (unarousable), while the score of 0 represents the alert and calm patient (alert and calm). Clinicians usually prefer to titrate and adjust sedation to light levels ranging between -1 and -2. Applying a plan of daily sedation interruption, combined with weaning protocols, also helps reduce the duration of mechanical ventilation, lower mortality rates and shorten the length of stay in the ICU.
Drug options and the risks of propofol infusion syndrome
Dexmedetomidine provides a unique sedation that mimics natural sleep, and is given to patients in intensive care by intravenous infusion at a rate of 0.2 to 1.2 µg/kg/h without the need for an initial loading dose (bolus). In contrast, Propofol carries the risk of a severe toxic syndrome known as Propofol infusion syndrome, which presents with metabolic acidosis, hyperkalaemia, rhabdomyolysis, fatty liver, refractory bradycardia and right bundle branch block. The likelihood of this serious syndrome rises when the infusion dose exceeds 5 mg/kg/h for longer than 48 hours or when used together with vasopressors or steroids.
Diagnosing delirium and non-pharmacological prevention
Hypoactive delirium, characterised by lethargy and drowsiness, is the most common pattern among intensive care patients, whereas the hyperactive pattern is evident through agitation and restlessness. To diagnose these conditions, the CAM-ICU tool is used, which becomes positive when the first feature (acute onset or fluctuation of symptoms) and the second feature (inattention and lack of focus) are present together with either the third feature (disorganised thinking) or the fourth feature (altered level of consciousness such that the RASS is not equal to zero). To reduce this problem, non-pharmacological preventive measures are adopted, including reorienting the patient, ensuring spectacles and hearing aids are available, and encouraging early mobilisation, while enhancing sleep quality by controlling lighting and ambient noise levels.
- The typical target for light sedation on the RASS scale is between -1 and -2, and a value of 0 means a calm and alert patient.
- Daily sedation interruption combined with weaning protocols reduces mortality, the duration of mechanical ventilation and length of stay.
- Propofol infusion syndrome occurs at doses exceeding 5 mg/kg/h for more than 48 hours and causes acidosis and cardiac and muscle dysfunction.
- Dexmedetomidine is given at 0.2–1.2 µg/kg/h without an initial loading bolus to produce sedation that mimics natural sleep.
- Hypoactive delirium is the most common, and the CAM-ICU tool relies on assessing attention, level of consciousness and thinking.
Sources
- Marino's The ICU Book, 4th ed., Ch. 51
- Miller's Basics of Anesthesia, 7th ed., pp. 719–720
- Miller's Basics of Anesthesia, 7th ed., pp. 718–719
- Miller's Basics of Anesthesia, 7th ed., p. 719
- Miller's Basics of Anesthesia, 7th ed., p. 720
- Marino's The ICU Book, 4th ed., Ch. 44
- Clinical Anesthesia Fundamentals, p. 770
Test yourself: 8 questions on this topic and many more →
Educational content for healthcare staff and students. It does not replace clinical judgement or your hospital protocol; check any dose against the reference and local guidance before use.